BSE filing, NSE: DOLPHMED. Summary written from the filing by ALFA Finder's alert engine.
Dolphin Medical Services Ltd: key numbers
- Share price
- ₹6.78
- Market cap
- ₹10.24 Cr
- Revenue (annual)
- ₹0.75 Cr
- Net profit (annual)
- ₹0.04 Cr
- P/E (TTM)
- 214.6×Sector 52.0×
- Promoter holding
- 100.00%+73.56% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Dolphin Medical Services Ltd
All →Dolphin Medical Services Other Announcement
Dolphin Medical Services Ltd filed its quarterly shareholding pattern as mandated by SEBI Regulation 31(1)(b). This document provides no material business event.
Dolphin Medical Services Management Change
Dolphin Medical Services appointed Mr. Kotha as Chairman and Promoter Director, reclassifying Mr. Mallour to Promoter Director. The board also reconstituted its committees.
Dolphin Medical Services Board Meeting Date
Dolphin Medical Services scheduled a board meeting for September 21, 2026. The agenda includes board appointments, committee reconstitution, and promoter reclassification.
Dolphin Medical Services Board Meeting Outcome
Dolphin Medical Services Limited announced the immediate resignation of its Managing Director and CEO, Mr. G V Mohan Prasad, and two other directors.
Dolphin Medical Services Annual General Meeting
Dolphin Medical Services Ltd received Registrar of Companies approval to extend its Annual General Meeting deadline by two months. The meeting is now scheduled for November 30, 2026.
- Execution
- 2 months extension
Dolphin Medical Services Open Offer: ₹0.01 Cr
Acquirers Amarandhar Reddy Kotha and Mallour Rajesh Kumar completed an open offer for Dolphin Medical Services Limited. They acquired 18,000 shares at ₹4.80 each, totaling ₹0.01 Crore.
- Value
- ₹0.01 Cr
Other board meeting date announcements
All →Tapi Fruit Processing Board Meeting Date
Tapi Fruit Processing will hold a board meeting on November 3, 2026 to consider unaudited standalone and consolidated half-yearly results for September 2026. Trading window closes from October 1 to November 5, 2026.
Parag Milk Foods Board Meeting Date
Parag Milk Foods has notified BSE of a board meeting on 3 November 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended 30 September 2026. Trading window closure runs from 1 October to 5 November 2026.
Vedant Fashions Board Meeting Date
Vedant Fashions will hold a board meeting on 5 November 2026 to consider unaudited results for the quarter and half-year ended September 2026. The meeting is a prior intimation, so no results are approved yet.
Dangee Dums Board Meeting Date
Dangee Dums will hold a board meeting on 2 November 2026 to consider unaudited standalone results for the quarter and half year ended 30 September 2026. Trading window closure runs until 4 November 2026.
Relic Technologies Board Meeting Date
Relic Technologies intimated a board meeting on 2 Nov 2026 to consider unaudited standalone and consolidated Q2 results for the period ended 30 Sep 2026. The trading window closes from 1 Oct 2026 until 48 hours after the results are disseminated.
EPL Board Meeting Date
EPL will hold a board meeting on November 4, 2026 to consider September quarter results. Trading window re-opens 48 hours after results are declared.